Glenmark Pharma launches Bumetanide Injection in single and multi-dose vials
The product is the generic version of Bumex 1 Injection, 0.25 mg/mL, of Validus Pharmaceuticals
Drug Discovery & Development | 11/01/2023 | By Sudeep Soparkar | 820
Zydus launches Topiramate extended-release capsules
Zydus is the first company to receive final approval and launch Topiramate Extended-Release Capsules, USP 25 mg, 50 mg, and 100 mg in the US
<br />
Drug Discovery & Development | 07/01/2023 | By Sudeep Soparkar | 831
Asymchem opens R&D site near Boston, Massachusetts
The new Boston site is focussed on providing early-stage R&D services including chemical process development, pre-formulation study and formulation development
<br />
Drug Discovery & Development | 20/12/2022 | By Sudeep Soparkar | 859
Freudenberg Medical unveils HelixFlex at CPhI & PMEC India
TPE tubing is ideal for pharmaceutical bioprocessing applications
Drug Discovery & Development | 30/11/2022 | By Sudeep Soparkar | 841
Cipla unveils Leuprolide Acetate Injection Depot 22.5mg
The injection is indicated for the palliative treatment of advanced prostate cancer
Drug Discovery & Development | 29/11/2022 | By Sudeep Soparkar | 1046
NATCO Pharma launches Pomalyst caps in Australia
The product was launched by NATCO’s commercial partner Juno Pharmaceuticals
Drug Discovery & Development | 09/11/2022 | By Sudeep Soparkar | 1215
With this new launch, the company aims to improve glycemic control in adult patients with uncontrolled type 2 diabetes
Drug Discovery & Development | 21/10/2022 | By Sudeep Soparkar | 692
Yapan Bio adds process development facility
Expands capacity and capabilities in large molecule therapeutics
Drug Discovery & Development | 19/10/2022 | By Sudeep Soparkar | 837
Baxter Pharma opens global pharma R&D Centre in Ahmedabad
The 20,500-square-foot, state-of-the-art R&D Centre features an array of sophisticated equipment and research labs that will focus on pharmaceutical product development
Drug Discovery & Development | 18/10/2022 | By Sudeep Soparkar | 2854
Piramal Pharma Solutions launches ADCelerate
ADCelerate is a new, branded solution for antibody-drug conjugate drug development
Drug Discovery & Development | 13/10/2022 | By Sudeep Soparkar | 565
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy